HPV vaccination provides a compelling opportunity to prevent six cancers and other diseases, but vaccine uptake in the United States and many other countries is too low to achieve its cancer prevention potential. In its 2012-2013 report, the President’s Cancer Panel concluded that underuse of HPV vaccines was a serious but correctable threat to progress against cancer. In this report, the Panel Chair provides an overview of progress made over the past five years and presents priorities and strategies to accelerate HPV vaccine uptake and eliminate the unnecessary burden of preventable HPV cancers.
Click here to start reading at the beginning or choose a section below. Click here to learn more about the President's Cancer Panel.